
Biodynamik Receives FDA IDE Approval for Pivotal U.S. Trial of XT3 System in Diabetic Foot Ulcers
Foothill Ranch, CA — April 2026 — Biodynamik, Inc., a medical device company advancing orthopedic-driven regenerative technologies, today announced that


















